This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Human medicines European public assessment report (EPAR): Azacitidine Mylan, aza...
Human medicines European public assessment report (EPAR): Pavblu, aflibercept, S...
In a webinar hosted by the medtech development service provider NAMSA, the forme...
Relay Therapeutics has laid off about 70 employees, the biotech's third round of...
Human medicines European public assessment report (EPAR): Lysodren, mitotane, Da...
A U.S. congressional commission has made the case for “swift action” to maintain...
Agenda of the CVMP meeting 8-10 April 2025
Veterinary medicines safety day: Social media infocards
Veterinary medicines safety day: How to report adverse events - simple guide
Veterinary medicines safety day: Adverse event reporting in the EU - presentation
Guidance on good manufacturing practice and good distribution practice: Question...
Innovation Task Force (ITF) briefing meeting request form
Republicans in Congress, long an unwavering source of support for privatized Med...
“Public health isn’t the sum of individual choices. It’s our collective agreemen...
The government already struggles to find licensees for many of its inventions, a...
Pain is the most costly chronic health problem in the U.S. In latest RIFs at NIH...
A federal commission is calling for $15 billion in new financing to re-enforce t...
SAN CARLOS, Calif.--(BUSINESS WIRE) April 3, 2025 -- BeiGene, Ltd. (NASDAQ: ONC;...
RADNOR, Pa., March 29, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Na...
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) ...
South San Francisco, CA -- April 3, 2025 -- Genentech, a member of the Roche Gro...
Paris, April 3, 2025. The US Food and Drug Administration (FDA) has granted orph...
San Diego, CA, USA, Berlin, Germany, April 3, 2025 – Vividion Therapeutics, Inc....